89 related articles for article (PubMed ID: 23322823)
1. Occurrence and significance of epithelial-mesenchymal transition in breast cancer.
Roxanis I
J Clin Pathol; 2013 Jun; 66(6):517-21. PubMed ID: 23322823
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
3. Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells.
Laezza C; D'Alessandro A; Paladino S; Maria Malfitano A; Chiara Proto M; Gazzerro P; Pisanti S; Santoro A; Ciaglia E; Bifulco M;
Eur J Cancer; 2012 Nov; 48(16):3112-22. PubMed ID: 22425263
[TBL] [Abstract][Full Text] [Related]
4. Cancer early dissemination: cancerous epithelial-mesenchymal transdifferentiation and transforming growth factor β signalling.
Sabe H
J Biochem; 2011 Jun; 149(6):633-9. PubMed ID: 21478191
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
[TBL] [Abstract][Full Text] [Related]
6. Endoplasmic reticulum protein 29 regulates epithelial cell integrity during the mesenchymal-epithelial transition in breast cancer cells.
Bambang IF; Lee YK; Richardson DR; Zhang D
Oncogene; 2013 Mar; 32(10):1240-51. PubMed ID: 22543584
[TBL] [Abstract][Full Text] [Related]
7. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
8. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
Fuxe J; Karlsson MC
Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
[TBL] [Abstract][Full Text] [Related]
9. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells.
Bocca C; Bozzo F; Cannito S; Parola M; Miglietta A
Mol Carcinog; 2012 Oct; 51(10):783-95. PubMed ID: 21882253
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.
Foroni C; Broggini M; Generali D; Damia G
Cancer Treat Rev; 2012 Oct; 38(6):689-97. PubMed ID: 22118888
[TBL] [Abstract][Full Text] [Related]
12. Emerging evidence of epithelial-to-mesenchymal transition in lung carcinogenesis.
Sato M; Shames DS; Hasegawa Y
Respirology; 2012 Oct; 17(7):1048-59. PubMed ID: 22452538
[TBL] [Abstract][Full Text] [Related]
13. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
14. Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment.
Suarez-Carmona M; Bourcy M; Lesage J; Leroi N; Syne L; Blacher S; Hubert P; Erpicum C; Foidart JM; Delvenne P; Birembaut P; Noël A; Polette M; Gilles C
J Pathol; 2015 Aug; 236(4):491-504. PubMed ID: 25880038
[TBL] [Abstract][Full Text] [Related]
15. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
Imamura T; Hikita A; Inoue Y
Breast Cancer; 2012 Apr; 19(2):118-24. PubMed ID: 22139728
[TBL] [Abstract][Full Text] [Related]
16. Beta-catenin/LEF-1 signalling in breast cancer--central players activated by a plethora of inputs.
Gebeshuber CA; Sladecek S; Grunert S
Cells Tissues Organs; 2007; 185(1-3):51-60. PubMed ID: 17587808
[TBL] [Abstract][Full Text] [Related]
17. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional and post-transcriptional regulation in TGF-β-mediated epithelial-mesenchymal transition.
Saitoh M; Miyazawa K
J Biochem; 2012 Jun; 151(6):563-71. PubMed ID: 22528665
[TBL] [Abstract][Full Text] [Related]
19. A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis.
Vincan E; Brabletz T; Faux MC; Ramsay RG
Cells Tissues Organs; 2007; 185(1-3):20-8. PubMed ID: 17587804
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer.
Gunasinghe NP; Wells A; Thompson EW; Hugo HJ
Cancer Metastasis Rev; 2012 Dec; 31(3-4):469-78. PubMed ID: 22729277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
